News

April 22, 2011 – The U.S. Food and Drug Administration (FDA) has cleared the Trifecta valve, by St. Jude Medical. The valve, a clinically-proven replacement for diseased, damaged or malfunctioning...

April 13, 2011 – Physician-researchers from the cardiac center at The Children’s Hospital of Philadelphia presented new findings on pediatric cardiovascular disease at the American College of...

April 11, 2011 — The following is a roundup of key news and trial data that came out of the American College of Cardiology (ACC) 2011 Scientific Session in New Orleans last week. ...

The transcatheter MitraClip mitral valve repair system continues to compare favorably with conventional open-heart surgery for treatment of select patients with mitral regurgitation. The findings...

A U.S.-Egyptian research team has uncovered the earliest documented case of coronary atherosclerosis in a princess who died in her early 40s and lived between 1580 and 1550 B.C.

April 6, 2011 – Data from the EVEREST II study show that patients with significant mitral regurgitation (MR) continue to show benefits from treatment with a catheter-based valve-clip system at one...

April 6, 2011 – Development of a novel embolic protection device designed for use during transcatheter aortic valve implantation (TAVI) procedures received $10.5 million in funding. SMT Research...

April 5, 2011 – Death rates are similar at one year for a catheter-based aortic valve replacement procedure and conventional surgery in older high-risk patients.

April 4, 2011 – A new system for treating mitral regurgitation (MR) has been launched in Australia. The MitraClip device, by Abbott, has received Therapeutic Goods Administration (TGA) approval...

March 29, 2011 – One-year outcomes from Cohort A of the PARTNER trial will be presented April 3 at the American College of Cardiology’s (ACC) 60th Annual Scientific Session and Expo in New Orleans...

March 15, 2011 – A new tricuspid ring for the treatment of tricuspid valve disease is approved for use in the United States, Europe and several other countries. The Contour 3D Annuloplasty Ring,...

March 14, 2011 – Expanding its transcatheter valve accessories with the addition of an aortic embolic protection device, Edwards Lifesciences Corp. completed the acquisition of Embrella...

March 14, 2011 – Sorin Group has reached a major milestone with the 100,000th MitroFlow Aortic Pericardial Heart Valve implantation worldwide.

March 4, 2011 - Occlutech GmbH received a favorable court ruling in Stockholm, Sweden in the ongoing patent litigation case with AGA Medical-St. Jude Medical.

Boston Scientific has completed its acquisition of Atritech. The completion of the transaction follows the signing of a definitive merger agreement announced on Jan. 19, 2011.

March 1, 2011 – A bioprosthetic heart valve has demonstrated positive performance at 12 years, according to a study published in The Journal of Thoracic and Cardiovascular Surgery....

February 25, 2011 – A larger transcatheter aortic heart valve has received the CE mark. The 29 mm version of the Sapien XT valve, from Edwards Lifesciences, promises to expand the number of...

February 18, 2011 – An independent study in the journal Circulation confirmed the early and sustained clinical benefits for a system treating aortic valve disease.

February 10, 2011 – Only about two out of every 100 babies (1.8 percent) are screened at birth for congenital heart defects (CHDs) because the hospital or birthing center does not routinely screen...

February 9, 2011 – The U.S. District Court for the District of Delaware reaffirmed an April 2010 federal jury decision that determined Medtronic CoreValve LLC willfully infringed Edwards...